Related references
Note: Only part of the references are listed.Tenascin-C serum levels and its prognostic power in non-small cell lung cancer
Florian Gebauer et al.
ONCOTARGET (2016)
HMGB1 induces angiogenesis in rheumatoid arthritis via HIF-1α activation
So Youn Park et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis
Jana Hurnakova et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Local Joint Inflammation and Histone Citrullination in a Murine Model of the Transition From Preclinical Autoimmunity to Inflammatory Arthritis
Dong Hyun Sohn et al.
ARTHRITIS & RHEUMATOLOGY (2015)
MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis
Ivy Y. Choi et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Transcriptome Assessment Reveals a Dominant Role for TLR4 in the Activation of Human Monocytes by the Alarmin MRP8
Selina K. Fassl et al.
JOURNAL OF IMMUNOLOGY (2015)
Selective Antibody Intervention of Toll-like Receptor 4 Activation through Fc γ Receptor Tethering
Limin Shang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity
Thomas Vogl et al.
NATURE COMMUNICATIONS (2014)
Combination of Tumor Necrosis Factor α and Interleukin-6 Induces Mouse Osteoclast-like Cells With Bone Resorption Activity Both In Vitro and In Vivo
Kazuhiro Yokota et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case-control study
Elizabeth V. Arkema et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Biologics-Based Therapy for the Treatment of Rheumatoid Arthritis
D. L. Scott
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Raised circulating tenascin-C in rheumatoid arthritis
Theresa H. Page et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Immune Complexes Containing Citrullinated Fibrinogen Costimulate Macrophages via Toll-like Receptor 4 and Fc gamma Receptor
Jeremy Sokolove et al.
ARTHRITIS AND RHEUMATISM (2011)
Toll-Like Receptor 4 Is Involved in Inflammatory and Joint Destructive Pathways in Collagen-Induced Arthritis in DBA1J Mice
Matthias Pierer et al.
PLOS ONE (2011)
The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab
Hilde Berner Hammer et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Although IL-6 Trans-Signaling Is Sufficient To Drive Local Immune Responses, Classical IL-6 Signaling Is Obligate for the Induction of T Cell-Mediated Autoimmunity
Rami Lissilaa et al.
JOURNAL OF IMMUNOLOGY (2010)
Endogenous ligands of TLR2 and TLR4: agonists or assistants?
Clett Erridge
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases
Athan Baillet et al.
RHEUMATOLOGY (2010)
Local Interleukin-1-Driven Joint Pathology Is Dependent on Toll-Like Receptor 4 Activation
Shahla Abdollahi-Roodsaz et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
Jan M. Ehrchen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease
Kim Midwood et al.
NATURE MEDICINE (2009)
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
Luke A. J. O'Neill et al.
PHARMACOLOGICAL REVIEWS (2009)
Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis
Walther J. van Venrooij et al.
YEAR IN IMMUNOLOGY 2008 (2008)
Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis
P. L. E. M. van Lent et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Shift From Toll-like Receptor 2 (TLR-2) Toward TLR-4 Dependency in the Erosive Stage of Chronic Streptococcal Cell Wall Arthritis Coincident With TLR-4-Mediated Interleukin-17 Production
Shahla Abdollahi-Roodsaz et al.
ARTHRITIS AND RHEUMATISM (2008)
TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock
Bruno Daubeuf et al.
JOURNAL OF IMMUNOLOGY (2007)
The extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4
Srie Prihianti Gondokaryono et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Mrp8 and Mrp14 are endogenous activators of Toll- like receptor 4, promoting lethal, endotoxin-induced shock
Thomas Vogl et al.
NATURE MEDICINE (2007)
Inhibition of toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis
Shahla Abdollahi-Roodsaz et al.
ARTHRITIS AND RHEUMATISM (2007)
HMGB1 signals through toll-like receptor (TLR) 4 and TLR2
Man Yu et al.
SHOCK (2006)
Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages
YI Miller et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Autoantibodies to citrullinated proteins: ACPA
C Vincent et al.
AUTOIMMUNITY (2005)
High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine
N Taniguchi et al.
ARTHRITIS AND RHEUMATISM (2003)
Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4
ST Smiley et al.
JOURNAL OF IMMUNOLOGY (2001)
The extra domain A of fibronectin activates toll-like receptor 4
Y Okamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
